Clinical Trials

It's very, very rare that you announce results at lunchtime, and it becomes policy and practice by tea time, and probably starts to save lives by the weekend - Martin Landray

Clinical Trials

image by: MinhChau Da

HWN Recommends

RECOVERY 1 year on: a rare success in the COVID-19 clinical trial landscape

On 23 March, the UK National Health Service’s RECOVERY trial marked its first anniversary. Initially set up to test four possible treatment options in a few thousand hospitalized COVID-19 patients, the platform trial is still going strong. It has now enrolled nearly 40,000 patients — just under 10% of the UK’s hospitalized COVID-19 patient population — into 13 treatment arms.

In a landscape marked by poorly designed and underpowered trials, RECOVERY stands out as a rare bright spot. Its results have demonstrated the benefits of the steroid dexamethasone and the IL-6-targeting antibody tocilizumab, while showing the lack of efficacy for azithromycin, colchicine, convalescent plasma,…

read full article


Related Articles

Stay Connected

©2021 | HealthWorldNet, Inc. | 115558

Last Updated : Sunday, September 5, 2021